See also this year's filing and all EDGAR filings for this company.
PDF Report 0001607678_2022_Viking_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001607678')"} |
Graph
Absolute values for 0001607678, Viking Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 210,528,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 134,000 |
| 4 | LiabilitiesCurrent | 8,778,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,701,000 |
| 9 | ResearchAndDevelopmentExpense | 44,981,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 692,000 |
| 13 | remainder_ComprehensiveNetIncome | -495,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 210,662,000 |
| 1 | Liabilities | 8,778,000 |
| 2 | Expenses | 55,682,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 201,884,000 |
| 5 | NetIncome | -54,990,000 |
| 6 | ComprehensiveNetIncome | -55,237,500 |
| 7 | BaseVar | 138,154,500 |
| 8 | EconomicCapitalRatio | 2.66 |
Edgar->Model Mapping
Feature Distribution
Change over Time
